双重超辐射方法用于甲状腺封闭性疾病
Yoshimitsu Soga1, Kento Matsui1, Kenji Ando1
1Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
JACC. Case reports
|August 1, 2025
概括
双重透射方法 (TRA) 提供了一个潜在的替代方案,用于治疗大关节闭塞病 (AIOD). 这种最少的侵入性技术成功地使患有严重AIOD的患者恢复血管,证明了其可行性.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 血管内干预 血管内干预
背景情况:
- 双重透射疗法 (TRA) 治疗大心血管封闭性疾病 (AIOD) 的有效性尚未得到充分证实.
- 传统的治疗方法往往涉及到移植方法,但这些方法带有特定的风险和局限性.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
Aneurysm III: Interprofessional Care
26
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
26
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29


